LPL Financial
DNTH icon

LPL Financial’s Dianthus Therapeutics DNTH Stock Holding History

LPL Financial’s Portfolio DNTH Stock Details DNTH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.37M Buy
65,295
+24,471
+60% +$2.14M ﹤0.01% 2572
2026
Q1 		$3.43M Buy
+40,824
New +$2.36M ﹤0.01% 2982

Other funds holding DNTH

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.51B AUM 546.08% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
APM
Avidity Partners Management Dallas, Texas $624M AUM 250.2% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $1.11B AUM 866.76% 1-Year Est. Return

LPL Financial's DNTH Position: Q2 2026 in Review

LPL Financial increased its Dianthus Therapeutics (DNTH) stake by 60% in Q2 2026, buying an estimated $2.14M and bringing the position to 65,295 shares worth $6.37M. The position accounts for ﹤0.01% of the portfolio, ranked #2572.

LPL Financial first reported a position in DNTH in Q1 2026 and has held it in 2 quarters since. 269 funds tracked by Wall St. Rank hold DNTH as of Q2 2026.

  • LPL Financial held 65,295 shares of Dianthus Therapeutics worth $6.37M as of Q2 2026.
  • LPL Financial bought 24,471 Dianthus Therapeutics shares in Q2 2026, an estimated $2.14M.
  • Dianthus Therapeutics made up ﹤0.01% of LPL Financial's portfolio in Q2 2026, its #2572 holding.
  • LPL Financial first reported a position in Dianthus Therapeutics in Q1 2026 and has held it in 2 quarters since.
  • 269 funds tracked by Wall St. Rank held Dianthus Therapeutics as of Q2 2026.

Based on LPL Financial's 13F filing for Q2 2026, filed 7 Aug 2026.